PhD Masahiko Sakoda MD

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The Kyushu Study Group of Clinical Cancer (KSCC) conducted phase II trials of KSCC1002 (UMIN000001308) concerning liver resectability after first-line treatment of initially unresectable or not(More)
Eiji Oki, MD, PhD, FACS, Yasunori Emi, MD, PhD, Yuji Miyamoto, MD, PhD, Akira Kabashima, MD, PhD, Hidefumi Higashi, MD, PhD, Yutaka Ogata, MD, PhD, Masahiko Ikebe, MD, PhD, Hiroshi Saeki, MD, PhD,(More)
  • 1